Moroccan pharma tycoon Lamia Tazi faces $3.35 million loss as Sothema shares dip
Lamia Tazi’s stake in Sothema dips below $65 million as shares slide
Sothema
Moroccan pharma tycoon Lamia Tazi suffers $2-million loss from Sothema stake
The recent financial setback experienced by Tazi underscores the broader challenges facing Sothema and highlights the unpredictable nature of the stock market.
Moroccan tycoon Lamia Tazi gains $2 million from Sothema stake in 8 days
The notable increase in the market value of Tazi’s stake in Sothema solidifies her position among the richest investors on the Casablanca bourse.
Moroccan tycoon Lamia Tazi’s Sothema stake slumps below $60 million
Despite the recent decline in her fortune, the Moroccan executive remains among the affluent investors on the Casablanca bourse.
Moroccan tycoon Lamia Tazi stake in Sothema rebounds above $60 million
Tazi’s recent financial gains are tied to the surge in Sothema’s stock on the Casablanca bourse.
Moroccan pharma tycoon Lamia Tazi suffers $3-million loss from Sothema stake
Tazi, the CEO and chairperson of Sothema holds a substantial 8.4-percent stake in the leading healthcare company.
Moroccan tycoon Lamia Tazi gains $6 million from Sothema stake in 15 days
The recent increase in the market value of her stake in Sothema solidifies her position among the richest investors on the Casablanca bourse.
Moroccan tycoon Lamia Tazi loses $2.8 million from Sothema stake
Lamia Tazi, the CEO and chairperson of Sothema and one of the most affluent investors on the Casablanca Stock Exchange, holds an 8.4-percent stake in the healthcare company
Led by Morocco’s wealthy Tazi family, pharma company Sothema looks to East Africa for growth
Sothema is controlled by the multimillionaire Tazi and Berrada families, who hold a combined stake of more than 70 percent.
Moroccan pharma tycoon Lamia Tazi suffers $3-million loss from Sothema stake
Tazi, the CEO and chairperson of Sothema holds a substantial 8.4-percent stake in the leading healthcare company.
Moroccan pharma tycoon Lamia Tazi’s year-to-date loss exceeds $17 million
Tazi, the CEO and chairperson of Sothema, owns a substantial 8.4-percent stake in the leading healthcare company.
Moroccan pharma tycoon Lamia Tazi suffers $9-million loss from Sothema stake
Tazi owns a substantial 8.4-percent stake in the leading healthcare company, or 605,030 issued shares.
Moroccan pharma tycoon Lamia Tazi loses more than $15 million from stake in Sothema
Tazi holds a substantial 8.4-percent stake in the leading healthcare company, or 605,030 issued shares.
Moroccan businesswoman Lamia Tazi loses nearly $11 million in 2 months
Tazi is one of the most affluent investors on the Casablanca Stock Exchange.
Moroccan tycoon Lamia Tazi set to receive $1.48-million dividend
Tazi holds a substantial 8.4-percent stake in Morocco’s leading healthcare company, Sothema, or 605,030 shares.
Moroccan businesswoman Lamia Tazi’s Sothema records over $27 million in profit in 2022
Tazi owns a significant 8.4-percent stake in Sothema.